Showing results (31-40 of 107) with videos related to

Sort By:
Pageof 11
Controlled Clinical Trials|December 14, 2004
An analysis of the effect of funding source in randomized clinical trials of second generation antipsychotics for the treatment of schizophreniaJohn H Montgomery, Matthew Byerly, Thomas Carmody, et al.
Journal of Affective Disorders|July 26, 2016
Early normalization of Quality of Life predicts later remission in depression: Findings from the CO-MED trialManish K Jha, Tracy L Greer, Bruce D Grannemann, et al.
Psychiatry Research|March 3, 2005
A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophreniaMatthew Byerly, Robert Fisher, Katrina Whatley, et al.
American Journal of Nephrology|September 5, 2016
Prognostic Utility of a Self-Reported Depression Questionnaire versus Clinician-Based Assessment on Renal OutcomesNishank Jain, Thomas Carmody, Abu T Minhajuddin, et al.
Brain Connectivity|September 13, 2022
BLENDS: Augmentation of Functional Magnetic Resonance Images for Machine Learning Using Anatomically Constrained WarpingKevin P Nguyen, Vyom Raval, Abu Minhajuddin, et al.
Journal of Affective Disorders|October 28, 2021
Comparison of inflammatory markers as moderators of depression outcomes: A CO-MED studyAndrew H Czysz, Brittany L Mason, Qiwei Li, et al.
The American Journal on Addictions|February 20, 2015
Men and women from the STRIDE clinical trial: An assessment of stimulant abstinence symptom severity at residential treatment entryKaren G Chartier, Katherine Sanchez, Therese K Killeen, et al.
The American Journal on Addictions|March 19, 2016
Baseline medical comorbidities in adults randomized in the STRIDE trial for psychostimulant use disordersAdriane M Dela Cruz, Thomas Carmody, Tracy L Greer, et al.
Iscience|April 23, 2025
Peripheral biological correlates of suicidality in children and adolescents: A systematic review and meta-analysisThomas K Pak, Emine Rabia Ayvaci, Thomas Carmody, et al.
Pageof 11